-

KBRA Releases Research – Normalization and the Risks to Credit

NEW YORK--(BUSINESS WIRE)--KBRA releases a report that examines the U.S. economy’s transition to “normalization” following extraordinary fiscal and monetary accommodation and the risks that transition poses to credit markets.

We are reminded that much of the current environment is not normal: economic growth and corporate earnings growth is running at twice longer-term averages, consumer and commercial default rates that are at structural lows, and household net worth has soared over the past two years. The cost underpinning all of that stimulus-fueled growth, including the worst inflation in 40 years, now threatens a soft landing. While we find that most U.S. consumers and businesses are well positioned to endure the “Great Deceleration,” we are keenly aware that slowing growth into a Fed tightening cycle, a still disruptive pandemic, and an increasingly risky geopolitical world will test asset valuations and will drive near- to medium-term recession risks up from very low levels.

Click here to view the report.

About KBRA
KBRA is a full-service credit rating agency registered in the U.S., the EU, and the UK, and is designated to provide structured finance ratings in Canada. KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.

Contacts

Van B. Hesser, Senior Managing Director and Chief Strategist
+1 (646) 731-2305
van.hesser@kbra.com

Joan Feldbaum-Vidra, Managing Director, Sovereigns
+1 (646) 731-2362
joan.feldbaumvidra@kbra.com

Business Development Contact

Dana Bunting, Senior Managing Director
+1 (646) 731-2419
dana.bunting@kbra.com

KBRA

Details
Headquarters: New York City, New York
CEO: Jim Nadler
Employees: 400+
Organization: PRI

Release Versions

Contacts

Van B. Hesser, Senior Managing Director and Chief Strategist
+1 (646) 731-2305
van.hesser@kbra.com

Joan Feldbaum-Vidra, Managing Director, Sovereigns
+1 (646) 731-2362
joan.feldbaumvidra@kbra.com

Business Development Contact

Dana Bunting, Senior Managing Director
+1 (646) 731-2419
dana.bunting@kbra.com

More News From KBRA

KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2)

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 71 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2). The transaction consists of 1,118 investment property mortgages with an aggregate principal balance of $438.4 million as of the March 1, 2026 cut-off date. The collateral is characterized by a weighted average (WA) original credit score of 770 and moderate borrower equity, with a WA original LTV and WA original CLTV of 73.2%. KBR...

KBRA Assigns Preliminary Ratings to Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to six classes of notes issued by Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1 (collectively “RPM 2026-R1”), an auto loan ABS transaction. RPM 2026-R1 has initial credit enhancement levels of 35.69% for the Class A notes to 2.65% for the Class E-2 notes. Credit enhancement is comprised of overcollateralization, subordination of junior note classes (except for the Class E-2 notes), a ca...

KBRA Releases Research – What’s up, Doc – Medical Professional Mortgages, A New Niche in RMBS?

NEW YORK--(BUSINESS WIRE)--KBRA releases research assessing the characteristics of medical professional mortgage (MPM) loans, with a focus on their potential role as a niche collateral segment within the prime private label residential mortgage-backed securities (RMBS) market. MPMs, often called physician or doctor loans, are specialized prime mortgage programs designed for medical professionals whose early-career financial profiles often include high student debt, limited savings, and reliance...
Back to Newsroom